Regulations.gov document
Memo to Docket re Internal Communications for Pepaxto
Other · FDA-2023-N-3167 · posted Feb 23, 2024
Key facts
| Document ID | FDA-2023-N-3167-0048 |
|---|---|
| Title | Memo to Docket re Internal Communications for Pepaxto |
| Document type | Other |
| Subtype | Memorandum |
| Agency | FDA |
| Docket | FDA-2023-N-3167 |
| Posted | Feb 23, 2024 |
| Comment period opens | Feb 23, 2024 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: